Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essentiality of Isoniazid in Tuberculosis Therapy
NCT01589497Phase 2Completed
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of isoniazid in pulmonary tuberculosis (TB) (4 arms). Primary endpoint: Daily Decrease in log10 Transformed Colony-forming Unit (CFU) Counts Per ml Sputum. Started Jun 2015; status: completed.
02
Drugs
isoniazid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01589497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589497.